Cholesterol balance is maintained by a series of regulatory pathways that c
ontrol the acquisition of cholesterol from endogenous and exogenous sources
and the elimination of cholesterol, facilitated by its conversion to bile
acids. Over the past decade, investigators have discovered that a family of
membrane-bound transcription factors, sterol regulatory element-binding pr
oteins (SREBPs), mediate the end-product repression of key enzymes of chole
sterol biosynthesis. Recently orphan members of another family of transcrip
tion factors, the nuclear hormone receptors, have been found to regulate ke
y pathways in bile acid metabolism, thereby controlling cholesterol elimina
tion. The study of these orphan nuclear receptors suggests their potential
as targets for new drug therapies.